PATENT CLAIM ANALYSIS

Application Number: 16030575
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "450000"]

Abstract:
The present invention provides a composition for the treatment of cancer including zwitterionic liposomes consisting essentially of: 50-65 mol % of a phosphatidylcholine lipid, 30-45 mol % of cholesterol, and 2-8 mol % of a PEG-lipid; and cisplatin. Cisplatin is encapsulated in the liposomes in an amount such that the ratio of the total lipid weight to the cisplatin weight is from about 65:1 to about 95:1. Methods for the preparation of liposomal cisplatin and the treatment of cancer are also disclosed.

Claim (Index 25):
The method of  claim 24 , wherein the phosphatidylcholine lipid in the composition is selected from the group consisting of palmitoyloleoylphosphatidylcholine (POPC), distearoylphosphatidylcholine (DSPC), dimyristoylphosphatidylcholine (DMPC) and dipalmitoylphosphatidylcholine (DPPC).

Metadata:
- Claim Count in Document: 62.0
- Percentile: 95.0
- Lexical Diversity: 1.67925
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14208297', '13664457', '15663472', '15162072', '13503614']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8047194531480618
- 35 USC 102 Novelty (BERT): 0.5964451951318454
- Combined Prediction Score: 0.7838920273464401
- Mean Citation Score: 391.876714
- Max Citation Score: 554.7429
- Similarity Product: 451.2606923092603

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test